+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

CellaVision AB (CEVI) - Financial and Strategic SWOT Analysis Review

  • PDF Icon

    SWOT Analysis

  • 40 Pages
  • July 2022
  • GlobalData
  • Cellavision AB
  • ID: 1495423
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

CellaVision AB (CEVI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.


CellaVision AB (CellaVision) is a medical technology company that provides digital solutions for medical microscopy in hematology. The company helps hematology laboratories improve and transform the analysis of blood and other body fluids. It has expertise in digital image analysis, automated microscopy and artificial intelligence. The company’s product portfolio includes analyzers for automated medical microscopy analysis, software, and applications for the healthcare and veterinary markets. It has partnerships with major companies that supply cell counters and other hematology equipment. Through its global partners, CellaVision distributes its products in the Americas, Middle East and Africa (EMEA) and Asia-Pacific. CellaVision is headquartered in Lund, Scania, Sweden.

CellaVision AB Key Recent Developments

Jan 13, 2022: Magnus Blixt leaves his position as CFO of CellaVision

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Section 1 - About the Company
  • CellaVision AB - Key Facts
  • CellaVision AB - Key Employees
  • CellaVision AB - Key Employee Biographies
  • CellaVision AB - Major Products and Services
  • CellaVision AB - History
  • CellaVision AB - Company Statement
  • CellaVision AB - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • CellaVision AB - Business Description
  • Product Category: Instruments
  • Performance
  • Product Category: Other
  • Performance
  • Product Category: Reagents
  • Performance
  • Geographical Segment: APAC
  • Performance
  • Geographical Segment: EMEA
  • Performance
  • Geographical Segment: The Americas
  • Performance
  • R&D Overview
  • CellaVision AB - Corporate Strategy
  • CellaVision AB - SWOT Analysis
  • SWOT Analysis - Overview
  • CellaVision AB - Strengths
  • CellaVision AB - Weaknesses
  • CellaVision AB - Opportunities
  • CellaVision AB - Threats
  • CellaVision AB - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • CellaVision AB, Medical Equipment, Deals By Year, 2016 to YTD 2022
  • CellaVision AB, Medical Equipment, Deals By Type, 2016 to YTD 2022
  • CellaVision AB, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • Jan 13, 2022: Magnus Blixt leaves his position as CFO of CellaVision
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About the Publisher
  • Contact the Publisher
  • Disclaimer
List of Tables
  • CellaVision AB, Key Facts
  • CellaVision AB, Key Employees
  • CellaVision AB, Key Employee Biographies
  • CellaVision AB, Major Products and Services
  • CellaVision AB, History
  • CellaVision AB, Other Locations
  • CellaVision AB, Subsidiaries
  • CellaVision AB, Key Competitors
  • CellaVision AB, Ratios based on current share price
  • CellaVision AB, Annual Ratios
  • CellaVision AB, Interim Ratios
  • CellaVision AB, Medical Equipment, Deals By Year, 2016 to YTD 2022
  • CellaVision AB, Medical Equipment, Deals By Type, 2016 to YTD 2022
  • CellaVision AB, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • CellaVision AB, Performance Chart (2017 - 2021)
  • CellaVision AB, Ratio Charts
  • CellaVision AB, Medical Equipment, Deals By Year, 2016 to YTD 2022
  • CellaVision AB, Medical Equipment, Deals by Type, 2016 to YTD 2022

Companies Mentioned

A selection of companies mentioned in this report includes:

  • ContextVision AB
  • Constitution Medical, Inc.
  • Circassia AB
  • Cellix Ltd
  • Biotage AB
  • Senzime AB